93 related articles for article (PubMed ID: 1551129)
1. Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine.
Cory JG; Cory AH; Long SD; Carter GL; Johnson CE
Cancer Res; 1992 Apr; 52(7):2000-3. PubMed ID: 1551129
[TBL] [Abstract][Full Text] [Related]
2. Deoxyadenosine-resistant mouse leukemia L1210 cell lines with alterations in early response genes and p53.
Cory JG; He AW; Cory AH
Anticancer Res; 1996; 16(6B):3483-9. PubMed ID: 9042210
[TBL] [Abstract][Full Text] [Related]
3. Effect of ionizing radiation on wild-type and mutant mouse leukemia L1210 cells.
He AW; Cory JG
Oncol Res; 1998; 10(9):455-64. PubMed ID: 10223621
[TBL] [Abstract][Full Text] [Related]
4. Effect of doxorubicin on wild-type and deoxyadenosine-resistant mouse leukemia L1210 cells.
He AW; Cory JG
Int J Oncol; 1999 May; 14(5):891-5. PubMed ID: 10200338
[TBL] [Abstract][Full Text] [Related]
5. Cell-cycle associated transcriptional regulation of ribonucleotide reductase in L1210 leukemia cells and drug-resistant variants.
Johnson CE; Hughes K; Cory JG
Cancer Commun; 1991; 3(10-11):341-9. PubMed ID: 1760249
[TBL] [Abstract][Full Text] [Related]
6. p53-independent anisomycin induced G1 arrest and apoptosis in L1210 cell lines.
He AW; Cory JG
Anticancer Res; 1999; 19(1A):421-8. PubMed ID: 10226577
[TBL] [Abstract][Full Text] [Related]
7. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
Cory JG; Carter GL
Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
[TBL] [Abstract][Full Text] [Related]
8. Cellular responses in mouse leukemia L1210 cells made resistant to deoxyadenosine.
Cory AH; Cory JG
Biochem Biophys Res Commun; 1998 Aug; 249(3):687-91. PubMed ID: 9731198
[TBL] [Abstract][Full Text] [Related]
9. Changes in messenger RNA levels for the subunits of ribonucleotide reductase during the cell cycle of leukemia L1210 cells.
Thompson DP; Carter GL; Cory JG
Cancer Commun; 1989; 1(4):253-60. PubMed ID: 2700914
[TBL] [Abstract][Full Text] [Related]
10. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
Futscher BW; Erickson LC
Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
[TBL] [Abstract][Full Text] [Related]
11. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
Tavassoli M; Shall S
Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
[TBL] [Abstract][Full Text] [Related]
12. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
Su ZZ; Yemul S; Stein CA; Fisher PB
Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
[TBL] [Abstract][Full Text] [Related]
13. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
14. c-myc and p53 gene expression in the differentiation of temperature-sensitive mutants of teratocarcinoma F9 cells.
Kosaka M; Iwai SA; Nishina Y; Sumi T; Nishimune Y
Oncogene; 1992 Dec; 7(12):2455-60. PubMed ID: 1461650
[TBL] [Abstract][Full Text] [Related]
15. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells.
Somerville L; Cory JG
Anticancer Res; 2000; 20(5B):3347-55. PubMed ID: 11131634
[TBL] [Abstract][Full Text] [Related]
16. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
17. Regulation of c-myc mRNA levels by insulin or platelet-poor plasma.
Gai XX; Rizzo MG; Valpreda S; Baserga R
Oncogene Res; 1989; 5(2):111-20. PubMed ID: 2691956
[TBL] [Abstract][Full Text] [Related]
18. [The expression of mRNA and SDS-PAGE of L1210 cell strains and its cloned cells].
Liu Q; Lu Z; Wang X; Liu F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):207-9. PubMed ID: 12947690
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-fos in human and murine multidrug-resistant cells.
Bhushan A; Abramson R; Chiu JF; Tritton TR
Mol Pharmacol; 1992 Jul; 42(1):69-74. PubMed ID: 1353251
[TBL] [Abstract][Full Text] [Related]
20. Increased rate of transcription contributes to elevated expression of the mutant p53 gene in Burkitt's lymphoma cells.
Bálint E; Reisman D
Cancer Res; 1996 Apr; 56(7):1648-53. PubMed ID: 8603415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
